2:04
- gma3
- October 13, 2020
Johnson & Johnson halts phase 3 COVID-19 vaccine trial
The drugmaker suffered a setback after a participant experienced an unexplained illness.
The drugmaker suffered a setback after a participant experienced an unexplained illness.